{"filings":[{"id":94472,"accession_number":"0001656472-26-000032","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2026-05-11T23:59:59+00:00","items":["1.01","2.02","8.01","9.01"],"status":"ready","headline":"Cronos Q1 net revenue up 40% to $45.2M; authorizes $50M share buyback; CanAdelaar close extended to Sep 9","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $45.2M (+40% YoY); net income $15.7M (+103%); adjusted EBITDA $5.1M (+122%).","Spinach brand reached #1 in Canadian vapes (9.8% share); PEACE NATURALS #1 in Israel with 53% revenue growth.","Board authorized $50M share repurchase program effective May 14, 2026 through May 13, 2027.","CanAdelaar acquisition long-stop date extended from June 9 to September 9, 2026 pending Dutch regulatory clearance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":45210000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106872,"accession_number":"0001656472-26-000015","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q4 2025 net revenue $44.5M (+47% YoY); net loss $0.5M vs income $43.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $44.5M, up 47% YoY; full-year net revenue $146.6M, up 25% YoY.","Q4 net loss $0.5M vs net income $43.9M in Q4 2024; Adjusted EBITDA improved to $0.5M from -$7.2M.","Full-year adjusted EBITDA $10.1M vs -$34.9M in 2024; gross margin improved to 43% from 21%.","Pending acquisition of CanAdelaar B.V. for €57.5M cash (~$67M) plus contingent earnout; expected close H1 2026.","Jared Kenost appointed Principal Accounting Officer and VP, Controller effective Feb 24, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":146587000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123198,"accession_number":"0001656472-25-000118","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Cronos to acquire CanAdelaar, Dutch cannabis market leader, for US$67M upfront plus earnouts","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Upfront consideration of €57.5M (US$67.0M) cash, plus earnout of 0.5x normalized EBITDA in 2026 and 2027.","CanAdelaar is the largest cannabis company in the Netherlands' adult-use pilot program (Wietexperiment), one of ten licensed growers.","Upfront consideration represents ~1.4x LTM revenue and ~2.4x LTM EBITDA (unaudited, Dutch GAAP, 12 months ended Sep 30, 2025).","Transaction expected to close in H1 2026, subject to regulatory approvals including Dutch Minister of Health and Bibob screening.","Acquisition unanimously approved by Cronos board; deal establishes footprint in Europe's largest adult-use cannabis market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123197,"accession_number":"0001656472-25-000100","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q3 net revenue $36.3M (+6% YoY); record Adj. EBITDA of $5.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $36.3M, up 6% YoY; gross profit $18.3M (50% margin) vs $3.6M (11%) a year ago.","Net income $28.3M vs $7.3M YoY; Adjusted EBITDA $5.7M vs ($6.0M) in Q3 2024.","Record net revenue in Israel; PEACE NATURALS #1 brand; Spinach #2 brand in Canada.","Cronos GrowCo expansion complete, sales commenced Fall 2025; cash $824M, debt-free.","International ex-Israel shipments shifted to Q4; H2 revenue expected in line with H1."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":102056000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139864,"accession_number":"0001656472-25-000083","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cronos terminates VP Controller Lloyd Wilson for cause effective Aug 29, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lloyd Wilson terminated as VP, Controller and Principal Accounting Officer for cause, effective immediately.","Company states termination is unrelated to financial results, operations, or internal controls.","No disagreements regarding the company's financial or reporting practices were cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139863,"accession_number":"0001656472-25-000077","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Cronos Q2 net revenue $33.5M (+21% YoY); adjusted EBITDA turns positive to $1.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $33.5M, up 21% YoY; adjusted gross margin improved to 43% from 23%.","Adjusted EBITDA of $1.7M vs -$11.1M a year ago; net loss widened to $38.5M on FX loss.","Record international and Israel revenue; PEACE NATURALS #1 cannabis brand in Israel.","Cronos GrowCo expansion complete; sales expected in fall 2025; anti-dumping duty vetoed in Israel.","Appointed Lloyd Wilson as principal accounting officer, replacing James McGinness."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":65717000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157457,"accession_number":"0001656472-25-000067","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cronos Group 2025 annual meeting: all director nominees elected, say-on-pay and auditor ratified","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Seven director nominees elected with over 206M votes for each; broker non-votes ~53.8M.","Advisory vote on executive compensation passed with 210.1M for, 12.6M against, 0.5M abstain.","Davidson & Company LLP ratified as auditor for FY2025 with 273.0M for, 3.95M withhold."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157456,"accession_number":"0001656472-25-000057","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Cronos Q1 net revenue $32.3M (+28% YoY), net income $7.7M; authorizes $50M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $32.3M (+28% YoY); net income $7.7M vs loss of $2.5M in Q1 2024.","Adjusted EBITDA $2.3M vs -$10.7M; adjusted gross margin 44% vs 18%.","Board authorized $50M share repurchase program; opens May 14, 2025, up to 19.3M shares.","PEACE NATURALS #1 cannabis brand in Israel; Spinach #2 brand in Canada with 4.6% share.","Cronos GrowCo cultivation expansion on track for Q2 completion; first sales H2 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":32262000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175828,"accession_number":"0001656472-25-000047","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-03-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cronos Group appoints Anna Shlimak as CFO; James Holm departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anna Shlimak appointed CFO effective March 19, 2025; James Holm ceases as CFO but remains employed through April 18, 2025.","Shlimak previously Chief Strategy Officer since Sep 2024; joined Cronos in 2018 as Head of IR.","Shlimak receives base salary $372,000, target bonus 115% of salary, one-time RSU award $157,800.","Holm receives cash severance $385,000 (one year salary), prorated bonus $104,046, and accelerated option vesting.","Holm subject to non-competition and non-solicitation covenants through April 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175827,"accession_number":"0001656472-25-000012","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q4 revenue up 27% YoY to $30.3M; reports net income of $43.9M vs prior year loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $30.3M (+27% YoY); full-year revenue $117.6M (+35% YoY).","Net income of $43.9M in Q4 (vs loss of $45.2M); full-year net income $40.0M (vs loss of $70.4M).","Adjusted EBITDA improved to -$7.2M in Q4 from -$14.8M; full-year -$34.9M from -$61.6M.","Spinach #1 cannabis brand in Canada; PEACE NATURALS #1 in Israel; achieved $8.7M operating expense savings in 2024.","Cash and equivalents $858.8M; Cronos GrowCo expansion on track for Q2 2025 completion."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":117615000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192738,"accession_number":"0001656472-24-000101","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q3 revenue up 38% to $34.3M; Spinach becomes #1 cannabis brand in Canada","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $34.3M, +38% YoY; net income $7.3M vs loss of $1.6M in Q3 2023.","Adjusted EBITDA loss improved 60% to $(6.0)M from $(15.2)M.","Spinach brand became #1 cannabis brand in Canada (Hifyre); #1 in edibles and flower categories.","Cash and cash equivalents $862M, up from $571.6M a year ago; short-term investments zero.","Cronos consolidated Cronos GrowCo; contributed $4.3M revenue; $51M facility for expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":87314000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209185,"accession_number":"0001656472-24-000088","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q2 net revenue rises 46% to $27.8M; net loss widens, Adj EBITDA improves","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $27.8M, up 46% YoY; gross profit $6.3M (+103%).","Net loss $8.8M vs $5.7M YoY; Adjusted EBITDA -$11.1M (improved from -$15.9M).","Cash and equivalents $848M; provided $51M credit facility to Cronos GrowCo for expansion.","Spinach #1 flower brand in Canada with 6.2% market share; Lord Jones #1 hash infused pre-roll.","Operating expense savings target $5-10M for 2024; net cash change no longer positive due to GrowCo investment."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":53050000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209184,"accession_number":"0001656472-24-000080","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K/A","filed_at":"2024-07-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cronos Group shareholders approve reappointment of Davidson & Company LLP as auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["On July 19, 2024, reconvened annual meeting approved auditor appointment.","Davidson & Company LLP reappointed as independent auditor for fiscal 2024.","Votes: 270,300,960 for, 3,834,201 withheld."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227080,"accession_number":"0001656472-24-000078","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-06-25T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Cronos ups GrowCo credit by C$70M to C$175M, secures supply rights for Phase 2","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Credit Agreement adds C$70M Term Loan B for Phase 2 cannabis facility; total facility now C$175M.","Term Loan A (C$105M) matures March 2031 at Prime+1.25%; Term Loan B matures 10 yrs after Phase 2 cultivation start.","Supply Agreement gives Cronos right to purchase 70-80% of GrowCo output at fixed prices for 4-year term.","Effective July 1, 2024, GrowCo board expands to 5 members; Cronos appoints 3, will consolidate results from Q3 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227079,"accession_number":"0001656472-24-000076","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-06-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cronos Group 2024 annual meeting results: directors elected, say-on-pay passes, auditor vote postponed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected; Michael Gorenstein received 204.4M votes for, 14.4M against.","Advisory say-on-pay resolution approved: 210.4M For, 8.0M Against, 0.3M Abstain.","Meeting adjourned to complete search for successor independent auditor; Proposal 3 not presented.","Adjournment motion passed: 216.7M For, 1.7M Against, 0.4M Abstain.","Company will disseminate details once successor auditor identified; no auditor named yet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227078,"accession_number":"0001656472-24-000071","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-05-28T23:59:59+00:00","items":["1.02","7.01","9.01"],"status":"ready","headline":"Cronos terminates sale-leaseback of Peace Naturals Campus after buyer fails condition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement terminated May 28, 2024; Future Farmco Canada did not satisfy due diligence/financing condition by May 27 deadline.","Security deposit held in trust returned to buyer per agreement terms.","Company evaluating strategic options for Peace Naturals Campus, including continuing or expanding operations.","Property is located in Stayner, Ontario at 4491 Concession 12 Sunnidale Road."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227077,"accession_number":"0001656472-24-000062","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q1 revenue up 30% YoY to $25.3M; net loss narrows; guidance reaffirmed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $25.3M (+30% YoY); gross profit $4.5M (+53%); net loss improved to $(2.5M) from $(18.0M).","Adjusted EBITDA of $(10.7M) improved $5.0M YoY; cash and equivalents $855M.","Spinach brand #1 flower and #3 vape in Canada; Lord Jones #1 hash infused pre-roll.","Launched PEACE NATURALS in UK via GROW Pharma partnership in May 2024.","Reiterated $5-10M operating expense savings target for 2024; expects positive net cash change."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":25288000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227076,"accession_number":"0001656472-24-000054","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cronos enters voting agreement with Altria for 2024 annual meeting support","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Altria agrees to vote its Cronos shares in favor of all company proposals at 2024 annual meeting.","Altria has rights to nominate four directors: Kamran Khan, Dominik Meier, Elizabeth Seegar, Murray Garnick.","Agreement covers proposals including director election; Altria may terminate if nominees not presented.","Voting agreement runs through earliest of Sept 26, 2024 or filing of final voting results.","Company must use best efforts to hold annual meeting by June 20, 2024; auditor proposal subject to Altria consultation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227075,"accession_number":"0001656472-24-000052","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Cronos Group auditor KPMG exits; will not seek re-appointment for 2024 audit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KPMG notified Cronos it will not stand for re-appointment for 2024 audit due to KPMG's decision to cease auditing cannabis companies.","KPMG issued unqualified opinions on financials for 2023 and 2022, but an adverse opinion on internal controls for 2022 (material weakness).","No disagreements between company and KPMG; company will promptly initiate search for a new auditor.","KPMG will continue to review Q1 and Q2 2024 quarterly results until replaced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227074,"accession_number":"0001656472-24-000045","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-04-03T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Cronos Group appoints Adam Wagner as Head of Cronos Israel; Gorelik becomes Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ran Gorelik steps down as GM of Cronos Israel effective April 2, 2024; becomes Chairman through April 1, 2026.","Gorelik's monthly base salary reduced to NIS 45,000 (Apr 2024–Mar 2025) then NIS 30,000 (Apr 2025–Apr 2026).","Gorelik eligible for annual bonus of NIS 189,000 (2024) and NIS 90,000 (2025); equity grants of $100k (2024) and $50k (2025).","Adam Wagner, formerly VP Finance of Cronos Israel, appointed Senior Vice President, Head of Cronos Israel, overseeing operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":245994,"accession_number":"0001656472-24-000017","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q4 net revenue up 9% YoY; net loss improves to $45M; cash balance $862M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $23.9M (+9% YoY); full-year net revenue $87.2M (+1% YoY).","Q4 net loss $45.2M, improved from $76.2M loss in Q4 2022; full-year net loss $70.4M vs $155.2M.","Adjusted EBITDA -$14.8M in Q4, improved $4.2M YoY; full-year -$61.6M, improved $8.7M.","Ended Q4 with ~$862M cash; expects positive cash flow in 2024 on ~$40-50M interest income and $5-10M cost savings.","Spinach brand #2 in Canada; launched Lord Jones in Canada; commenced Australia sales; Israel-Hamas war hit Israel sales."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":87241000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}